Margaret T. Lee

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.

T. Haferlach, S. Schnittger, W. Kern, 2010, Blood.

Lymphoblastic Leukemia (all) Molecular Study of Minimal Residual Disease (mrd) in Adult Acute Improved Risk Classification for Risk-specific Therapy Based on The

T. Barbui, A. Bosi, A. Gallamini, 2022 .

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

R. Gascoyne, L. Sehn, J. Connors, 2007, Blood.